CLINICAL_TRIALS
trial_result
· 2023-08-15
Clinical Trial Update: Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50 [Phase 3]
Summary
Phase 3 trial investigating ivermectin to prevent COVID-19–related hospitalization in adults over 50 was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Insud Pharma | Conditions: COVID-19, SARS-CoV-2 | Phase 3 | Status: TERMINATED